Skip to main content
. Author manuscript; available in PMC: 2008 Oct 8.
Published in final edited form as: HIV Med. 2008 Apr;9(4):196–202. doi: 10.1111/j.1468-1293.2008.00545.x

Table 4.

Multivariate analysis of factors associated with hazardous alcohol use (compared to moderate or none) among individuals on highly active antiretroviral therapy (n = 641)

Variable Multivariate OR (95% CI)
Sex
 Female 1.0 (Ref)
 Male 1.55 (0.78–3.11)
Race/ethnicity
 White 1.0 (Ref)
 African American 0.48 (0.23–1.00)
 Hispanic 1.92 (0.82–4.48)
 Other 0.27 (0.03–2.29)
Insurance
 Private 1.0 (Ref)
 Medicaid 1.42 (0.60–3.38)
 Medicare 1.14 (0.37–3.48)
 Medicaid/Medicare 1.24 (0.51–3.00)
 None 2.96 (1.10–7.94)*
CD4 nadir (cells/μL)
 < 50 1.0 (Ref)
 50–199 1.70 (0.84–3.44)
 200–499 1.71 (0.80–3.64)
 ≥ 500 1.76 (0.60–5.15)
 Missing 2.82 (0.81–9.80)
Adherence
 < 95% 1.0 (Ref)
 ≥ 95% 0.49 (0.28–0.85)*
Illicit drug use
 Never 1.0 (Ref)
 Former 1.64 (0.76–3.57)
 Current 2.61 (1.25–5.47)*
Primary care visits
 ≤ 3 visits 1.0 (Ref)
 4–5 visits 0.80 (0.36–1.80)
 6–7 visits 0.93 (0.45–1.90)
 ≥ 8 visits 0.32 (0.14–0.75)*

Multivariate analysis includes only those covariates with P < 0.20 in bivariate analysis. Analysis adjusted for site CI, confidence interval; OR, odds ratio.

*

P < 0.05.